At a glance
- Originator Gifu Pharmaceutical University
- Class Antineoplastics
- Mechanism of Action Thymidylate synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 18 Jun 2001 No-Development-Reported for Cancer in Japan (Unknown route)